CRY Insider Trading Activity and SEC Form 4 Filings
CRY insider trading summary
No open-market insider purchases or sales of Cryolife Inc (CRY) have been reported on SEC Form 4 in the past 12 months.
Latest CRY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 8, 2021 | Amy Horton | VP, Chief Accounting Officer | Sell | $46K (2,500 @ $18.57) |
| Nov 29, 2021 | John E Davis | Senior VP, Global Sales | Buy | $10K (600 @ $17.33) |
| Nov 29, 2021 | Anthony B. Semedo | Director | Buy | $260K (15,000 @ $17.36) |
| Aug 31, 2021 | Jean F Holloway | SVP, General Counsel | Sell | $18K (663 @ $26.49) |
| Aug 25, 2021 | Ronald D McCall | Director | Sell | $145K (5,667 @ $25.63) |
| Aug 23, 2021 | Dennis B Maier | Vice President, Operations | Sell | $70K (2,715 @ $25.64) |
| May 25, 2021 | John E Davis | Senior VP, Global Sales | Sell | $26K (880 @ $29.70) |
| May 25, 2021 | John E Davis | Senior VP, Global Sales | Sell | $160K (5,402 @ $29.67) |
| May 25, 2021 | John E Davis | Senior VP, Global Sales | Sell | $191K (6,457 @ $29.65) |
| May 25, 2021 | Ronald D McCall | Director | Sell | $171K (5,783 @ $29.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.